139 related articles for article (PubMed ID: 26416034)
1. CD44 single nucleotide polymorphism and isoform switching may predict gastric cancer recurrence.
Suenaga M; Yamada S; Fuchs BC; Fujii T; Kanda M; Tanaka C; Kobayashi D; Fujiwara M; Tanabe KK; Kodera Y
J Surg Oncol; 2015 Nov; 112(6):622-8. PubMed ID: 26416034
[TBL] [Abstract][Full Text] [Related]
2. Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
Stotz M; Herzog SA; Pichler M; Smolle M; Riedl J; Rossmann C; Bezan A; Stöger H; Renner W; Berghold A; Gerger A
Anticancer Res; 2017 Apr; 37(4):2011-2018. PubMed ID: 28373475
[TBL] [Abstract][Full Text] [Related]
3. Association of Two CD44 Polymorphisms with Clinical Outcomes of Gastric Cancer Patients.
Bitaraf SM; Mahmoudian RA; Abbaszadegan M; Mohseni Meybodi A; Taghehchian N; Mansouri A; Forghanifard MM; Memar B; Gholamin M
Asian Pac J Cancer Prev; 2018 May; 19(5):1313-1318. PubMed ID: 29802692
[TBL] [Abstract][Full Text] [Related]
4. Epithelial to mesenchymal transition might be induced via CD44 isoform switching in colorectal cancer.
Mashita N; Yamada S; Nakayama G; Tanaka C; Iwata N; Kanda M; Kobayashi D; Fujii T; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
J Surg Oncol; 2014 Nov; 110(6):745-51. PubMed ID: 24975268
[TBL] [Abstract][Full Text] [Related]
5. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
[TBL] [Abstract][Full Text] [Related]
6. MDM4 genetic variants and risk of gastric cancer in an Eastern Chinese population.
Wang MY; Jia M; He J; Zhou F; Qiu LX; Sun MH; Yang YJ; Wang JC; Jin L; Wang YN; Wei QY
Oncotarget; 2017 Mar; 8(12):19547-19555. PubMed ID: 28099948
[TBL] [Abstract][Full Text] [Related]
7. Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer.
Wu CL; Chao YJ; Yang TM; Chen YL; Chang KC; Hsu HP; Shan YS; Lai MD
BMC Cancer; 2015 Nov; 15():903. PubMed ID: 26572077
[TBL] [Abstract][Full Text] [Related]
8. CD44 variant 9 expression as a predictor for gastric cancer recurrence: immunohistochemical and metabolomic analysis of surgically resected tissues.
Yamakawa Y; Kusuhara M; Terashima M; Kinugasa Y; Sugino T; Abe M; Mochizuki T; Hatakeyama K; Kami K; Yamaguchi K
Biomed Res; 2017; 38(1):41-52. PubMed ID: 28239031
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of CD44 variant 9 expression as a prognostic indicator in bladder cancer.
Kobayashi K; Matsumoto H; Matsuyama H; Fujii N; Inoue R; Yamamoto Y; Nagao K
Oncol Rep; 2016 Nov; 36(5):2852-2860. PubMed ID: 27599396
[TBL] [Abstract][Full Text] [Related]
10. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
11. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome.
Yamanoi K; Arai E; Tian Y; Takahashi Y; Miyata S; Sasaki H; Chiwaki F; Ichikawa H; Sakamoto H; Kushima R; Katai H; Yoshida T; Sakamoto M; Kanai Y
Carcinogenesis; 2015 May; 36(5):509-20. PubMed ID: 25740824
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer.
Kodama H; Murata S; Ishida M; Yamamoto H; Yamaguchi T; Kaida S; Miyake T; Takebayashi K; Kushima R; Tani M
Br J Cancer; 2017 Jan; 116(2):186-194. PubMed ID: 27931044
[TBL] [Abstract][Full Text] [Related]
14. REGIV as a potential biomarker for peritoneal dissemination in gastric adenocarcinoma.
Moon JH; Fujiwara Y; Nakamura Y; Okada K; Hanada H; Sakakura C; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
J Surg Oncol; 2012 Feb; 105(2):189-94. PubMed ID: 21780125
[TBL] [Abstract][Full Text] [Related]
15. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer.
Kang BW; Jeon HS; Chae YS; Lee SJ; Park JY; Choi JE; Park JS; Choi GS; Kim JG
PLoS One; 2015; 10(3):e0119649. PubMed ID: 25799222
[TBL] [Abstract][Full Text] [Related]
16. Association of the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and survival in the Korean population.
Ahn DH; Rah H; Choi YK; Jeon YJ; Min KT; Kwack K; Hong SP; Hwang SG; Kim NK
Mol Carcinog; 2013 Nov; 52 Suppl 1():E39-51. PubMed ID: 23001871
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of cancer stem cell marker gene CD133 are associated with susceptibility and prognosis of gastric cancer.
Jia ZF; Wu YH; Cao DH; Cao XY; Jiang J; Zhou BS
Future Oncol; 2017 May; 13(11):979-989. PubMed ID: 28326835
[TBL] [Abstract][Full Text] [Related]
18. Associations between single-nucleotide polymorphisms of the VEGF gene and long-term prognosis of oral squamous cell carcinoma.
Kämmerer PW; Koch FP; Schiegnitz E; Kumar VV; Berres M; Toyoshima T; Al-Nawas B; Brieger J
J Oral Pathol Med; 2013 May; 42(5):374-81. PubMed ID: 23227881
[TBL] [Abstract][Full Text] [Related]
19. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
